ICON Public Limited Company
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ICLR research report →
Companywww.iconplc.com
ICON Public Limited Company, a clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally. The company specializes in the strategic development, management, and analysis of programs that support various stages of the clinical development process from compound selection to Phase I-IV clinical studies. It offers clinical development services, including early development, patient recruitment and retention, strategy and analytics, late phase research, data and technology solution, and consulting and analytics services.
- CEO
- Barry Balfe
- IPO
- 1998
- Employees
- 41,250
- HQ
- Dublin, IE
Price Chart
Valuation
- Market Cap
- $8.71B
- P/E
- 14.72
- P/S
- 1.08
- P/B
- 0.95
- EV/EBITDA
- 10.02
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 26.85%
- Op Margin
- 12.15%
- Net Margin
- 7.40%
- ROE
- 6.32%
- ROIC
- 6.85%
Growth & Income
- Revenue
- $8.28B · 1.99%
- Net Income
- $791.47M · 29.26%
- EPS
- $9.60 · 28.69%
- Op Income
- $1.10B
- FCF YoY
- 9.63%
Performance & Tape
- 52W High
- $211.00
- 52W Low
- $66.57
- 50D MA
- $109.92
- 200D MA
- $153.20
- Beta
- 1.23
- Avg Volume
- 1.17M
Get TickerSpark's AI analysis on ICLR
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 14, 26 | Murphy Ronan Martin | other | 5,005 |
| May 14, 26 | Murphy Ronan Martin | sell | 5,005 |
| May 14, 26 | CLIMAX JOHN DR | other | 5,005 |
| May 14, 26 | CLIMAX JOHN DR | sell | 5,005 |
| May 14, 26 | McCague Eugene Pacelli | other | 3,255 |
| May 14, 26 | McCague Eugene Pacelli | sell | 3,255 |
| Mar 18, 26 | Balfe Barry Edward | other | 0 |
| Mar 18, 26 | Balfe Barry Edward | other | 886 |
| Mar 18, 26 | Balfe Barry Edward | other | 1,664 |
| Mar 18, 26 | Balfe Barry Edward | other | 4,480 |
Our ICLR Coverage
We haven't published any research on ICLR yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ICLR Report →